Defunct Company
Total Trials
12
As Lead Sponsor
9
As Collaborator
3
Total Enrollment
1,277
NCT00068172
Study of PI-88 in Patients With Advanced Melanoma
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jul 31, 2001
Completion: Jun 30, 2007
NCT00073892
PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma
Start: Jan 31, 2004
Completion: Nov 30, 2005
NCT00097851
Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)
Phase: Phase 2
Start: Feb 29, 2004
Completion: Jul 31, 2006
NCT00103389
Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Completion: May 31, 2007
NCT00247728
PI-88 in Hepatocellular Carcinoma After Hepatectomy
Start: Jun 30, 2004
Completion: Jun 30, 2008
NCT00130442
Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma
Start: Jun 30, 2005
Completion: Oct 31, 2010
NCT01142050
Stem Cell Therapy for Type 2 Diabetes Mellitus
Phase: Phase 1
Start: Aug 31, 2010
Completion: Dec 31, 2011
NCT01143168
Stem Cell Therapy for Type 1 Diabetes Mellitus
NCT01402908
A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resection
Phase: Phase 3
Start: Aug 31, 2011
Completion: Jan 31, 2015
NCT01468064
Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke
Role: Collaborator
Start: Nov 30, 2011
Completion: Mar 31, 2017
NCT02804334
The Role of Molecules in Blood Cells for Diagnosing Bipolar Disorders
Phase: N/A
Start: Jun 30, 2016
Completion: Oct 31, 2018
NCT02909504
Gao NARASD Lithium Study
Phase: Phase 4
Start: Sep 30, 2016
Completion: Nov 30, 2018